文献速递会诊联络精神医学

全球精神疾病患者癌症筛查差异:患病率与比较meta分析(含4717839人)

Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people.
PubMed 文献 · Lancet Psychiatry · 2019-11-29

BACKGROUND: Since people with mental illness are more likely to die from cancer, we assessed whether people with mental illness undergo less cancer screening compared with the general population.…

要点

  • 乳腺癌、宫颈癌和前列腺癌筛查在精神疾病患者中显著更少。

核心结论

  • 尽管精神疾病患者癌症死亡率更高,但该人群接受的癌症筛查少于一般人群。
  • 应制定具体方法帮助精神疾病患者接受适当的癌症筛查,尤其是精神分裂症女性。

研究设计与样本

  • 系统综述与meta分析,检索PubMed和PsycINFO(无语言限制)并手工检索参考文献,纳入截至2019年5月5日的观察性研究。
  • 使用Newcastle-Ottawa量表评估研究质量(中位7分,IQR 6-8),I2评估异质性,PROSPERO注册号CRD42018114781。

临床怎么用

  • 精神科临床应关注精神疾病患者的癌症筛查不足问题,尤其是乳腺癌、宫颈癌和前列腺癌筛查。
  • 对精神分裂症女性等高风险群体,应主动协助其接受适当的癌症筛查。

局限性

  • 肺癌、胃癌和卵巢癌筛查仅各纳入1项研究,证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Since people with mental illness are more likely to die from cancer, we assessed whether people with mental illness undergo less cancer screening compared with the general population. METHODS: In this systematic review and meta-analysis, we searched PubMed and PsycINFO, without a language restriction, and hand-searched the reference lists of included studies and previous reviews for observational studies from database inception until May 5, 2019. We included all published studies focusing on any type of cancer screening in patients with mental illness; and studies that reported prevalence of cancer screening in patients, or comparative measures between patients and the general population. The primary outcome was odds ratio (OR) of cancer screening in people with mental illness versus the general population. The Newcastle-Ottawa Scale was used to assess study quality and I2 to assess study heterogeneity. This study is registered with PROSPERO, CRD42018114781. FINDINGS: 47 publications provided data from 46 samples including 4 717 839 individuals (501 559 patients with mental illness, and 4 216 280 controls), of whom 69·85% were women, for screening for breast cancer (k=35; 296 699 individuals with mental illness, 1 023 288 in the general population), cervical cancer (k=29; 295 688 with mental illness, 3 540 408 in general population), colorectal cancer (k=12; 153 283 with mental illness, 2 228 966 in general population), lung and gastric cancer (both k=1; 420 with mental illness, none in general population), ovarian cancer (k=1; 37 with mental illness, none in general population), and prostate cancer (k=6; 52 803 with mental illness, 2 038 916 in general population). Median quality of the included studies was high at 7 (IQR 6-8). Screening was significantly less frequent in people with any mental disease compared with the general population for any cancer (k=37; OR 0·76 [95% CI 0·72-0·79]; I2=98·53% with publication bias of Egger's p value=0·025), breast cancer (k=27; 0·65 [0·60-0·71]; I2=97·58% and no publication bias), cervical cancer (k=23; 0·89 [0·84-0·95]; I2=98·47% and no publication bias), and prostate cancer (k=4; 0·78 [0·70-0·86]; I2=79·68% and no publication bias), but not for colorectal cancer (k=8; 1·02 [0·90-1·15]; I2=97·84% and no publication bias). INTERPRETATION: Despite the increased mortality from cancer in people with mental illness, this population receives less cancer screening compared with that of the general population. Specific approaches should be developed to assist people with mental illness to undergo appropriate cancer screening, especially women with schizophrenia. FUNDING: None.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Solmi M, Firth J, Miola A, et al. Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people. Lancet Psychiatry. 2019. PMID: 31787585. doi:10.1016/S2215-0366(19)30414-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。